Uncategorized
Novo CEO sees innovation as a matter of survival amid pipeline setbacks
Novo CEO sees innovation as a matter of survival amid pipeline setbacks
The FDA has been trying to mend fences with rare disease drug developers and patient groups since the departure of former Commissioner Marty Makary three months ago. But advisory committee meetings last week for Replimune and Capricor Therapeutics only created more confusion and frustration.
Uncategorized
Gilead looks to upcoming inflammation, cancer catalysts as pressure to diversify mounts
HIV remained Gilead’s strongest franchise in the second quarter, but the pharma is building out its pipeline beyond virology, particularly focusing on inflammation and oncology.
Uncategorized
STAT+: Moderna launches early trial of Ebola mRNA vaccine
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got a busy earnings week. Here’s the latest.
The need-to-know this morning
- Amgen and Gilead Sciences reported earnings last night.
- United Therapeutics reported earnings this morning.
Novo vs. Lilly
The two GLP-1 giants have both reported earnings.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got a busy earnings week. Here’s the latest.
The need-to-know this morning
- Amgen and Gilead Sciences reported earnings last night.
- United Therapeutics reported earnings this morning.
Novo vs. Lilly
The two GLP-1 giants have both reported earnings.
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, Prasad
Gilead looks to upcoming inflammation, cancer catalysts as pressure to diversify mounts
STAT+: Moderna launches early trial of Ebola mRNA vaccine
Novo CEO sees innovation as a matter of survival amid pipeline setbacks
Enzene Targets Local Biomanufacturing with New Solutions
A COPD drug from China draws $115M in venture funding
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
-
Fierce Biotech4 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Endpoints News5 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
-
Uncategorized4 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
-
Uncategorized9 years ago
According to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years ago
Uber and Lyft are finally available in all of New York State